Atelerix Life Sciences Inc. Press Releases - EIN Presswire

Published on September 27, 2023 - 17:29 GMT

Atelerix Life Sciences Inc. Announces BARDA Contract to Support First-in-Human Clinical Trial of ATLX-0199

New therapeutic treatment being developed to reverse respiratory depression CHARLOTTESVILLE, VA, UNITED STATES, September 27, 2023 /⁨EINPresswire.com⁩/ -- Atelerix Life Sciences Inc., a leader in new therapeutics for unmet medical needs related to …

Distribution channels: Healthcare & Pharmaceuticals Industry ...

Published on November 22, 2021 - 16:31 GMT

Peter Barton Hutt Joins Atelerix Life Sciences Board of Directors

Distinguished Counsel and FDA Regulatory Scholar Will Lend His Expertise on Corporate and Strategic Matters CHARLOTTESVILLE, VA, UNITED STATES, November 22, 2021 /⁨EINPresswire.com⁩/ -- Atelerix Life Sciences Inc., a leader in new therapeutics for unmet …

Distribution channels: Banking, Finance & Investment Industry, Companies ...

Published on September 14, 2021 - 19:14 GMT

Atelerix Life Sciences Appoints James Bates, MD, as Chief Medical Officer

CHARLOTTESVILLE, VA, UNITED STATES, September 14, 2021 /⁨EINPresswire.com⁩/ -- Atelerix Life Sciences Inc., a leader in new therapeutics for unmet medical needs related to opioid use, today announced the appointment of James Bates, MD, PhD, to the position …

Distribution channels: Culture, Society & Lifestyle, Emergency Services ...

Published on May 19, 2021 - 20:58 GMT

Atelerix Life Sciences Announces Publication Demonstrating Reversal of Opioid Induced Respiratory Depression

CHARLOTTESVILLE, VA, UNITED STATES, May 19, 2021 /⁨EINPresswire.com⁩/ -- Atelerix Life Sciences Inc., a Charlottesville, Virginia-based biotechnology company developing novel small molecule therapeutics for the treatment of unmet opioid-related medical …

Distribution channels: Banking, Finance & Investment Industry, Business & Economy ...